AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2015
Feb 18, 2015
30016_dirs_2015-02-18_8ecc0686-6af3-4079-a9c3-1c45f9a72df4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-02-14
Reporting Person: JUNIUS DANIEL M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-14 | Deferred Stock Unit | $ | A | 37 | Acquired | Common Stock (37) | Direct | |
| 2015-02-14 | Non-Qualified Stock Option (right to buy) | $159.08 | A | 449 | Acquired | 2025-02-13 | Common Stock (449) | Direct |
Footnotes
F1: This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from his election to the IDEXX Laboratories, Inc. Board of Directors on 03/11/2014 to 05/07/2014, the date of the annual equity grant made to all Directors.
F2: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest fully on 05/06/2015 and are payable as common stock one year following the Director's resignation from the Board of Directors.
F3: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests fully on 05/06/2015.